Opportunities and Challenges of Cell and Gene Therapy Development

2:30 PM - 3:45 PM, Monday, June 3, 2019 ・ 105AB, Level 100
Our industry has been shaped by an ever-changing landscape, with emerging science disrupting the status quo to offer new hope for patients with unmet medical needs. Cell and gene therapies (CT/GT products) are the latest wave of advanced technologies shaping the face of the modern-day arena. During this session, speakers will reflect on the cross-functional opportunities and significant challenges they faced in early development of CT/GT products in addition to discussing future milestones and anticipated obstacles along the way. Attendees will receive a real-world perspective on the development of CT/GT products from peers who have been in their shoes.
Sr. Vice President, CMC Operations
Executive Partner
MPM Capital
ARM (Alliance for Regenerative Medicine)
Director, Preclinical Development
Astellas Institute of Regenerative Medicine